Gynecological Devices and Instruments Market Size was valued at USD 7.98 Billion in 2023. The Global Gynecological Devices and Instruments industry is projected to grow from USD 10.56 Billion in 2024 to USD 15.67 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 13.56% during the forecast period (2024 - 2032).
It is noted that the improvement in reimbursement policies is the key factor driving the market of gynecological devices and instruments. According to the recent 2018 hysterectomy reimbursement fact sheet, suggested by the Centers for Medicare and Medicaid Services (CMS), the average Medicare payment for supracervical abdominal hysterectomy is USD 983. Whereas, for vaginal hysterectomy, laparoscopy-assisted supracervical Hysterectomy, and laparoscopy-assisted vaginal hysterectomy, the average Medicare payment is USD 1004, USD 915, and USD 1008, respectively.
Various other factors such as the increasing cases of gynecological issues, improving regulatory framework, growing research funding, unmet medical needs, rising competition among market players, increasing number of gynecology surgeries, emerging Asian markets, and increasing government assistance are continuously contributing to the growth of the global market of gynecological devices and instruments.
Despite these drivers, there are some issues associated with the market of gynecological devices and instruments. The high cost of treatment, lack of skilled or trained physicians, and poor healthcare system in low and middle-income countries may hamper the growth of the market.
Developments in improved imaging instruments, such as 3D endoscopes, and innovations in gynecological gadgets that increase the efficacy of minimally invasive surgical techniques are forecasted to fuel the market. increased awareness of women's health issues, technological improvements, the increased incidence of gynecological problems, and the increasing popularity of minimally invasive surgical techniques all play a role.
Product demand is predicted to increase due to rising interest in surgical treatments such female sterilization, ablation, endoscopy, and laparoscopy, as well as rising utilization of disposable items. Industry expansion is forecasted in part because of the increasing popularity of cutting-edge technologies. The epidemic has hastened the process of digitizing medical equipment and other parts of the healthcare system. AI and ML can improve gynecological device administration for a variety of conditions.
February 2023:Samsung introduced an AI-enabled ob/gyn ultrasound system in February 2023. According to Samsung, the HERA W10 Elite system's maker, the system's 2D and 3D visualization of microcirculatory and slow blood with the Advanced MV-Flow feature and large organic light-emitting diode (OLED) display offer better characterization of diverse ultrasound images. HeartAssistTM, an AI-enhanced function of the HERA W10 Elite, offers automated measurement views to aid in fetal heart diagnosis.
In June 2023:Ceek Women's Health will release the Nella Single-Use Vaginal Speculum, which they believe will transform the delivery of gynecological care forever. With considerable consideration given to patient comfort, the Nella Single-Use Vaginal Speculum was made to be as thin as a tampon. It has built-in sidewall retractors and an LED light to help doctors see the cervical area more clearly when doing gynecological exams and treatments. The universal fit makes it easier to track inventory, and the vaginal walls and cervix may be illuminated without hindrance from fluids with the help of the LED light built into the top bill.
The newly chosen cornerback for the NFL, Kelee Ringo, along with his mother and cancer survivor, Tralee Hale, has collaborated with Hologic Inc., a global leader in women’s wellbeing on a campaign that was held on May 08, 2023, to guide females upon the advantages of annual mammography and other important health screenings.
Stryker (NYSE: SYK), one of the global topmost medical technology companies, gave the statement that it had finalized the acquisition on May 02, 2023, of Cerus Endovascular Ltd., which is privately held, commercial-stage, and engaged in making neuro-interventional equipment utilized in the treatment of intracranial aneurysms.
Boston Imaging, or Samsung Corporation, is a US-based corporation which manufactures and sells mainly the medical imaging technology devices or equipments. It launched Hera W10 Elite AI-enabled women's health ultrasound images that is specfically constructed for the utilization in obstetrics and gynecology procedures to bring diagnostic insights closer to clinicians. Additionally, it ulitizes a novel transducer that is useful for endovaginal visualization of the fetal heart and brain.
September 2022:Guardenia Contained Extraction System will be available for purchase in September 2022 from Olympus, a world leader in the development and distribution of advanced technologies for medical and surgical applications. Advanced Surgical Concepts (ASC) Ltd. of Bray, Ireland, has released Guardenia, the newest addition to their line of confined tissue extraction products for use in gynecological surgeries. The system is sold only in the United States by Olympus America Inc., and it is used to isolate and confine tissue before and/or after surgical removal and/or extracorporeal manual morcellation.
September 2022 bore witness to Olympus Corporation’s announcement about VISERA ELITE III being its latest surgical visualization platform tailored for all surgical specialties, including gynecology.
In July 2022, GE Healthcare announced that Voluson Expert 22 utilizes patented graphic-based beam former innovative technology that enhances the image quality and gives greater flexibility within imaging functions. This is the most latest ultrasound system ever developed by GE Healthcare.
In June 2022, UroViu Corp launched Hystero-V, which was introduced into the market alongside the Always Ready endoscopy platform compatible single-use hysteroscope. The semi-rigid Hystero-V is hydrophilic coated, thus offering gentle insertion and superior visualization during intra-uterine procedures.
Endoluxe Company from California launched the Endoluxe eVS HD wireless endoscopic camera in March 2022, equipped with TowerTech used in gynecological surgeries as well as other ENT/urology/ orthopedic/general surgeries.
The market of gynecological devices and instruments is segmented on the basis of type of surgical devices, type of surgical instruments, application, and end-user.
On the basis of type of surgical devices, the gynecological devices and instruments market is classified as gynecological endoscopy devices, endometrial ablation devices, fluid management systems, and female sterilization/contraceptive devices. The gynecological endoscopy devices are further segmented into hysteroscope, colposcope, resectoscope, laparoscope, and endoscopic imaging systems. Endometrial ablation devices are further segmented into hydrothermal ablation devices, Radiofrequency ablation devices, balloon ablation devices, and others. Female sterilization/contraceptive devices are further segmented into permanent birth control and temporary birth control. The temporary birth control segment includes IUD, intravaginal rings, and subdermal contraceptive implants.
On the basis of type of surgical instruments, the market for gynecological devices and instruments is classified as forceps, scissors, trocars, needle holders, vaginal speculums, dilators, uterine sounds, uterine depressors, uterine curettes, and others. The forceps segment is further classified as Allis forceps, artery forceps, and other forceps. The vaginal speculums segment is further classified as sim’s vaginal speculums, Cusco vaginal speculums, graves’ vaginal speculums, pediatric vaginal speculums, Pederson vaginal speculums, and others.
On the basis of application, the market for gynecological devices and instruments is classified as laparoscopy, hysteroscopy, dilation and curettage, colposcopy, cervical cryosurgery, endometrial ablation, endometrial biopsy, and others.
On the basis of end-user, the market is classified as hospitals and clinics, ambulatory surgery centers, research and academic institutes, and others.
The Americas dominates the gynecological devices market owing to the increasing prevalence of gynecological problems, well-developed technology, high healthcare expenditure, and the presence of leading players. According to the statistics suggested by the Center for Disease Control and Prevention (CDC), cervical cancer is one of the leading causes of deaths of women in the United States. It is reported that in 2014, around 12,578 women in the United States were diagnosed with cervical cancer, and nearly 4,115 women in the United States died from cervical cancer.
Europe holds the second position in the market of gynecological devices and instruments. It is expected that the rising contribution towards research and development and increasing competition among marketers are likely to drive the European gynecological devices and instruments market.
Asia Pacific is the fastest growing gynecological devices and instruments market owing to a huge patient pool, increasing demand for treatment, and rising healthcare expenditure. As per the data suggested by the Australian Institute of Health and Welfare during the year 2015–2016, the total health expenditure was nearly USD 170.4 billion, i.e., 3.6% higher than the expenditure in 2014–2015. The initiatives taken by the government towards gynecological issues are also boosting the market growth. For instance, the Pradhan Mantri Surakshit Matritva Abhiyan (PMSMA) initiated by the Ministry of Health and Family Welfare in 2016, is focusing towards the reduction of maternal and infant mortality rates through safe pregnancies and safe deliveries. This national programme supported around three crore pregnant women across the country by providing special free antenatal care. The main aim of the programme is to detect and prevent high-risk pregnancies.
The Middle East and Africa holds the lowest share of the global market of gynecological devices and instruments due to low development, lack of technical knowledge, and poor medical facilities.
Some of the key players in the global gynecological devices and instruments market are
| Report Attribute/Metric | Details |
| Market Size 2023 | 7.98 (USD Billion) |
| Market Size 2024 | 10.56 (USD Billion) |
| Market Size 2032 | 15.67 (USD Billion) |
| Compound Annual Growth Rate (CAGR) | 13.56 % (2024 - 2032) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2023 |
| Market Forecast Period | 2024 - 2032 |
| Historical Data | 2019 - 2023 |
| Forecast Units | Value (USD Billion) |
| Segments Covered | Type, Application, and End-User |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Thermo Fisher Scientific Inc., Avantor, Becton, Dickinson and Company, Beckman Coulter, Inc., Merck KGaA, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Water Corporation, bioMérieux SA |
| Key Market Opportunities | Increasing government support, rising investments in healthcare, and the presence of a well-established pharmaceutical market |
| Key Market Drivers | Increasing applications of gynecological devices in diagnostics, rising interest in minimally invasive surgeries, technological advancements, and improved reimbursement policies |
Gynecological Devices Instruments Market Highlights:
Frequently Asked Questions (FAQ) :
The gynecological devices and instruments market has been projected to grow with 13.56% CAGR during the forecast period containing 2024 to 2032
End users with a proper link with the gynecological devices and instruments market are research & academic institutes, ambulatory surgery centers, hospitals & clinics, and others.
The Americas would maintain their domination over the gynecological devices and instruments market.
The Asia Pacific region has the scope to register the fastest speed in the gynecological devices and instruments market.
The gynecological devices and instruments market would be influenced by the competitive market, better regulatory framework, hike in research funding, a surge in gynecological issues, unmet medical needs, emerging economies, an increasing number of gynecology surgeries, and improved government assistance.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
